Pharma Focus Asia
Eppendorf Bioprocess Solutions

Umoja Biopharma Opens New Manufacturing Facility in Louisville, Colorado, US


Umoja Biopharma, plans for the construction of new manufacturing facility. The new facility will be dedicated for the production of next-generation CAR T immunotherapies.


The state-of-the-art facility designed with 146,000 square foot will overcome the production barriers and delivers effective, accessible cancer treatments.

The new facility features house labs, offices, and manufacturing space for the production of lentiviral vector. In addition, it will further improve the vector manufacturing, process development, and formulation capabilities.

This investment in the new facility is committed to bring new therapies to cancer patients and also will be used for how these therapies are produced, stored, and distributed.

The construction of the manufacturing facility is expected to start its operation in first quarter of 2023.


NameUmoja Biopharma
TypeNew Construction
Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEACPHI Korea 2023Bora Pharmaceutical - A robust approach to analytical testing is essentialSelangor International Expo MEDIC 2023TFS - Webinar - DynaSpin™ Single-Use Centrifuge for harvest applicationsMedical Fair Thailand 2023ThermoFisher Scientific - NEW Mobile AppCPHI & PMEC China 20233rd ANNUAL COMPUTER SOFTWARE ASSURANCE 2023Pharma Regulatory Conclave 202320th Anniversary Hospitalog Asia 2023
Charles River Laboratories - Endosafe Compendial LAL Cartridge Technology